BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, December 8, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
See today's BioWorld Science
Home
» SNORA47 and SNORD126 behind prognosis of nonviral hepatocellular carcinoma
To read the full story,
subscribe
or
sign in
.
Biomarkers
SNORA47 and SNORD126 behind prognosis of nonviral hepatocellular carcinoma
June 7, 2024
Hepatocellular carcinoma (HCC) still accounts for a high mortality rate and poor prediction of outcomes and survival.
BioWorld Science
Conferences
Biomarkers
International Liver Congress
Cancer